APPLICATION
ANDA040832
TYPE
ANDA
ORIGINAL APPROVAL
2010-01-07
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CARISOPRODOL AND ASPIRINDiscontinued
ASPIRIN 325MG, CARISOPRODOL 200MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 3 · standardAP
2021-04-30Labeling · Supplement 1 · standardAP
2010-01-07OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.